Assessment and correlates of autistic symptoms in Schizophrenia Spectrum Disorders measured with the PANSS Autism Severity Score: A systematic review.

PAUSS autism cognition functioning neurobiology schizophrenia

Journal

Frontiers in psychiatry
ISSN: 1664-0640
Titre abrégé: Front Psychiatry
Pays: Switzerland
ID NLM: 101545006

Informations de publication

Date de publication:
2022
Historique:
received: 01 05 2022
accepted: 12 08 2022
entrez: 16 9 2022
pubmed: 17 9 2022
medline: 17 9 2022
Statut: epublish

Résumé

Schizophrenia Spectrum Disorders (SSD) and Autism Spectrum Disorders (ASD) are considered separate entities, but the two spectra share important similarities, and the study of these areas of overlap represents a field of growing scientific interest. The PANSS Autism Score (PAUSS) was recently developed specifically to assess autistic symptoms in people living with SSD reliably and quickly. The aims of the present systematic review were to provide a comprehensive assessment of the use of the PAUSS scale in available literature and to systematically analyze cognitive, functional and neurobiological correlates of autistic symptoms measured with this instrument in SSD. The systematic literature search included three electronic databases (PubMed, Scopus and PsycINFO) as well as a manual search in Google Scholar and in reference lists of included papers. Screening and extraction were conducted by at least two independent reviewers. Out of 213 identified records, 22 articles referring to 15 original studies were included in the systematic review. Studies were conducted in several different countries by independent groups, showing consistent scientific interest in the use of the scale; most works focused on cognitive and functional correlates of ASD symptoms, but some also considered neurobiological features. Results of included studies showed that autistic symptoms in people with SSD are consistently associated with worse cognitive performance, especially in the social cognition domain, and with worse psychosocial functioning. However, the presence of autistic symptoms appears to also have a protective role, particularly on functioning, in subjects with more severe psychotic symptoms. Further exploring the impact of autistic symptoms could be of significant scientific and clinical interest, allowing the development of tailored interventions to improve treatment for people living with SSDs.

Identifiants

pubmed: 36111306
doi: 10.3389/fpsyt.2022.934005
pmc: PMC9468543
doi:

Types de publication

Systematic Review

Langues

eng

Pagination

934005

Informations de copyright

Copyright © 2022 Nibbio, Barlati, Calzavara-Pinton, Necchini, Invernizzi, Dell'Ovo, Lisoni, Deste and Vita.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

Am J Med Genet. 2000 Spring;97(1):12-7
pubmed: 10813800
Schizophr Res. 2020 Jan;215:113-119
pubmed: 31780344
Nature. 2014 Jan 16;505(7483):361-6
pubmed: 24352232
Int J Environ Res Public Health. 2020 May 12;17(10):
pubmed: 32408561
J Pharmacol Exp Ther. 2016 Sep;358(3):504-15
pubmed: 27384073
Schizophr Res. 2014 Sep;158(1-3):264-5
pubmed: 24999051
Psychol Med. 2021 Jul;51(10):1704-1713
pubmed: 32151297
J Am Acad Child Adolesc Psychiatry. 2009 Jan;48(1):10-8
pubmed: 19218893
Schizophr Bull. 2022 Jan 21;48(1):273-282
pubmed: 34313767
J Psychiatr Res. 2021 May;137:48-54
pubmed: 33652326
Annu Rev Clin Psychol. 2013;9:555-87
pubmed: 23537488
World Psychiatry. 2021 Feb;20(1):4-33
pubmed: 33432763
PLoS Med. 2009 Jul 21;6(7):e1000097
pubmed: 19621072
JAMA Psychiatry. 2018 Apr 1;75(4):396-404
pubmed: 29450447
J Autism Dev Disord. 2001 Feb;31(1):19-28
pubmed: 11439750
Int J Dev Neurosci. 2005 Apr-May;23(2-3):125-41
pubmed: 15749240
Front Psychiatry. 2022 Mar 30;13:801651
pubmed: 35432047
BMJ. 2021 Mar 29;372:n71
pubmed: 33782057
Syst Rev. 2017 Dec 06;6(1):245
pubmed: 29208034
Neuropsychiatr Dis Treat. 2020 Oct 29;16:2553-2561
pubmed: 33154642
J Int Neuropsychol Soc. 2020 Mar;26(3):276-285
pubmed: 31507263
Schizophr Res. 2017 Feb;180:28-35
pubmed: 27567291
Schizophr Bull. 2016 Mar;42(2):494-504
pubmed: 25943125
Eur Child Adolesc Psychiatry. 2004 Aug;13(4):201-8
pubmed: 15365889
Psychol Med. 2020 Nov;50(15):2557-2565
pubmed: 31576783
Psychol Med. 2017 Oct;47(14):2472-2482
pubmed: 28436341
Cereb Cortex. 2022 Aug 3;32(16):3406-3422
pubmed: 34875687
EMBO Mol Med. 2015 Nov 26;7(12):1565-79
pubmed: 26612855
Mol Psychiatry. 2018 Feb;23(2):476-486
pubmed: 27922606
Br J Psychiatry. 2009 May;194(5):418-25
pubmed: 19407271
Psychol Med. 2022 Mar 08;:1-11
pubmed: 35257646
Eur Psychiatry. 2020 Nov 10;63(1):e98
pubmed: 33168115
JAMA Psychiatry. 2021 Aug 1;78(8):848-858
pubmed: 33877289
J Clin Psychiatry. 2017 Nov/Dec;78(9):e1233-e1241
pubmed: 29125721
Mol Psychiatry. 2022 Jul;27(7):2976-2984
pubmed: 35422471
Schizophr Res. 2016 Mar;171(1-3):16-26
pubmed: 26817402
BMC Psychiatry. 2015 May 13;15:115
pubmed: 25968177
Behav Brain Sci. 2008 Jun;31(3):241-61; discussion 261-320
pubmed: 18578904
Eur Psychiatry. 2021 Feb 18;64(1):e23
pubmed: 33597064
Front Psychiatry. 2020 Mar 26;11:187
pubmed: 32273855
Front Psychiatry. 2019 Feb 21;10:78
pubmed: 30846948
Schizophr Res. 2017 May;183:102-109
pubmed: 28291690
Schizophr Bull. 1987;13(2):261-76
pubmed: 3616518
Schizophr Bull. 2014 May;40(3):602-16
pubmed: 23686020
Psychol Med. 2020 Jul;50(10):1623-1632
pubmed: 31298174
PLoS One. 2010 Aug 18;5(8):e12233
pubmed: 20805880
Schizophr Res. 2021 Oct;236:12-18
pubmed: 34364032
Brain Res. 2011 Mar 22;1380:34-41
pubmed: 21078305
J Psychiatr Res. 2018 Sep;104:96-99
pubmed: 30015265
Vertex. 2010 Sep-Oct;21(93):394-400
pubmed: 21218204
J Autism Dev Disord. 1989 Jun;19(2):185-212
pubmed: 2745388
Schizophr Res Cogn. 2020 Jul 27;22:100186
pubmed: 32760657
PLoS Biol. 2021 Apr 19;19(4):e3001162
pubmed: 33872298
Front Psychiatry. 2020 Jun 05;11:524
pubmed: 32581892
Psychol Med. 2019 Jan;49(1):140-148
pubmed: 29554995
Front Psychiatry. 2021 Jan 26;12:622359
pubmed: 33574776
Eur Psychiatry. 2017 Feb;40:116-122
pubmed: 27997875
Am J Psychiatry. 2014 Jun;171(6):627-39
pubmed: 24577245
BMC Psychiatry. 2021 Sep 23;21(1):464
pubmed: 34556056
J Psychiatry Neurosci. 2018 Feb 05;43(2):170094
pubmed: 29402375
Int J Evid Based Healthc. 2015 Sep;13(3):147-53
pubmed: 26317388
Curr Opin Neurol. 2014 Apr;27(2):149-56
pubmed: 24565942
Schizophr Res. 2016 Aug;175(1-3):12-19
pubmed: 27083780
J Neural Transm (Vienna). 2008;115(1):135-8
pubmed: 17768593
Br J Psychiatry. 2017 Apr;210(4):269-275
pubmed: 27979819
Psychiatry Res. 2018 Dec;270:764-768
pubmed: 30551322
World Psychiatry. 2014 Oct;13(3):275-87
pubmed: 25273301
Rev Psiquiatr Salud Ment (Engl Ed). 2020 Jul - Sep;13(3):118-130
pubmed: 32703733
J Psychiatr Res. 2019 Aug;115:36-42
pubmed: 31102902
Front Psychiatry. 2020 Aug 07;11:798
pubmed: 32848955
J Autism Dev Disord. 1994 Oct;24(5):659-85
pubmed: 7814313
Psychiatry Res. 2020 Jun;288:112950
pubmed: 32361335
CNS Spectr. 2021 Apr 12;:1-11
pubmed: 33843551
BMJ Open. 2019 Sep 3;9(9):e030342
pubmed: 31481564
Transl Psychiatry. 2017 Oct 10;7(10):e1247
pubmed: 28994820
Aust N Z J Psychiatry. 2022 Jul;56(7):818-827
pubmed: 34376088
Int J Evid Based Healthc. 2019 Mar;17(1):58-71
pubmed: 30256247
BMC Psychiatry. 2010 Nov 10;10:91
pubmed: 21067598
Am J Psychiatry. 2011 May;168(5):472-85
pubmed: 21406461
Schizophr Res. 2022 May;243:364-371
pubmed: 34183209
Neuropsychology. 2019 Feb;33(2):195-202
pubmed: 30346197
Neuroreport. 2019 Nov 6;30(16):1062-1067
pubmed: 31464839
Dev Neurobiol. 2014 Feb;74(2):113-22
pubmed: 24124131
Front Psychiatry. 2020 Aug 28;11:806
pubmed: 33005149
PLoS One. 2011;6(6):e20982
pubmed: 21687627
Hist Human Sci. 2013 Jul;26(3):3-31
pubmed: 24014081
Front Psychiatry. 2018 Oct 24;9:504
pubmed: 30459645
Schizophr Bull. 2018 Jun 6;44(4):737-748
pubmed: 28981848
Schizophr Res Cogn. 2019 Oct 31;19:100164
pubmed: 31832344
Psychiatry Res. 2017 Oct;256:359-364
pubmed: 28686933

Auteurs

Gabriele Nibbio (G)

Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy.

Stefano Barlati (S)

Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy.
Department of Mental Health and Addiction Services, ASST Spedali Civili of Brescia, Brescia, Italy.

Irene Calzavara-Pinton (I)

Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy.

Nicola Necchini (N)

Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy.

Elena Invernizzi (E)

Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy.

Dario Dell'Ovo (D)

Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy.

Jacopo Lisoni (J)

Department of Mental Health and Addiction Services, ASST Spedali Civili of Brescia, Brescia, Italy.

Giacomo Deste (G)

Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy.
Department of Mental Health and Addiction Services, ASST Spedali Civili of Brescia, Brescia, Italy.

Antonio Vita (A)

Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy.
Department of Mental Health and Addiction Services, ASST Spedali Civili of Brescia, Brescia, Italy.

Classifications MeSH